Medical Review by Jennie Stanford, MD, FAAFP Summary: GLP-1 medications (like Ozempic and Wegovy) can help with weight loss, but plateaus are a normal part of the process
Feldman, and R
The Social Security Act defines medical necessity for Medicare as "reasonable and necessary for the diagnosis or treatment of illness or injury." Weight loss for obesity does not qualify as treatment of illness under Medicare's interpretation, which is why Medicare Part D cannot cover Wegovy
They add that the pill has also proven effective in reducing the risk of major cardiovascular events such as heart attack, stroke, or death in those who are also at high risk for these events
Ozempic led to an average loss of up to 4.7 kg (about 10 lbs) over 30 weeks, based on clinical trial comparisons
CrossRef Landscape of Somatic and AgeRelated Pathogenic Structural Variations in Hepatocellular Carcinoma Revealed by LongRead Sequencing Zhewen Wei, Yinghao Cao, Hongchao Liu, Mei Liu, Bolun Zhang, Jianming Ying, Jianqiang Cai, Xinyu Bi, Jianjun Zhao, Jianguo Zhou, Zhiyu Li, Zhen Huang, Jianmei Liu, Xueyan Lv, Zhiwen Luo, Zhicheng Wei, Xiaoshi Zhang, Yi Yang, Yiqiao Deng, Yanjiang Yin, Jin MedComm .2026;[Epub] CrossRef Gastrointestinal cancer statistics in 2022 and projection to 2050: GLOBOCAN estimates across 185 countries Pojsakorn Danpanichkul, Yanfang Pang, Primrose Tothanarungroj, Disatorn Dejvajara, Donghee Kim, Preenapun Saokhieo, Kanokphong Suparan, Mark D